Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Heijink, M. Jonker, D. Postma, M. Van den Berge (Groningen, Netherlands). Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium. Eur Respir J 2014; 44: Suppl. 58, 958

Member's Comments

No comment yet.

Related content which might interest you: Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Interaction between aclidinium bromide and formoterol fumarate in small human airways Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Comparison of budesonide and fluticasone propionate on COPD macrophage phagocytosis and killing of bacteria Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Initial interaction of fluticasone propionate with ciliated respiratory epithelium Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children Source: International Congress 2016 – Mechanisms of disease Year: 2016 Differential effects of budesonide and fluticasone propionate on bacterial recognition receptors in COPD macrophages Source: International Congress 2016 – Airway response to infection Year: 2016 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 COPD airway epithelium secretion attracts and activates neutrophils Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status Source: International Congress 2014 – Asthma and COPD management Year: 2014 Corticosteroid plus long-acting beta2-agonist prevent virus-associated upregulation of B7-H1/PD-L1 on airway epithelium Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Effects of combining tiotropium and salmeterol/fluticasone propionate on airway dimensions in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013